PharmaEngine
4162.TWO
3.45 USD
0.09
+2.68%
p
Overview
Last close
3.45 usd
Market cap
495.73M usd
52 week high
3.68 usd
52 week low
2.42 usd
Target price
3.66 usd
Valuation
P/E
43.9689
Forward P/E
N/A
Price/Sales
19.5158
Price/Book Value
4.0778
Enterprise Value
381.53M usd
EV/Revenue
15.0288
EV/EBITDA
27.1486
Key financials
Revenue TTM
25.39M usd
Gross Profit TTM
23.98M usd
EBITDA TTM
12.03M usd
Earnings per Share
0.08 usd
Dividend
0.05 usd
Total assets
127.78M usd
Net debt
N/A usd
About
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
- Symbol4162.TWO
- ExchangeTWO
- IsinTW0004162003
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Hong-Ren Wang Ph.D.
- HeadquarterTaipei
- Web sitehttps://www.pharmaengine.com
